If EHang's core business — certified pilotless passenger eVTOL — were disrupted or shut down, the company does not show much evidence of a ready-made second core to fall back on. Virtually all of its cash, headcount, capex and management attention over the past decade have gone into this one product architecture and this one regulatory relationship, and the closest thing to a hedge, aerial-media revenue (roughly 40% of Q1 2026's small revenue base), is both too small and too undifferentiated to function as an actual Plan B. The one genuine precedent for reinvention is early and partial: EHang's original business was consumer drones (the Ghost line, plus the CES 2016 debut of the single-seat EHang 184 concept), and when that did not work commercially, the company's former U.S. and German sales subsidiaries filed for bankruptcy in 2017 as EHang exited consumer drones in those markets and refocused on enterprise and passenger autonomous aircraft. Being willing to abandon a failing line and re-center the business is a real, positive data point on adaptability — but it happened via subsidiary bankruptcy rather than an orderly wind-down, which suggests the execution of that pivot was blunt rather than sophisticated, and it was a far smaller, earlier-stage bet than "the whole company's core is disrupted" would require today.
On admitting mistakes and bad news, the record is a genuine pattern, not a single episode, and it recurs around the same weak point each time: order and revenue quality. Wolfpack Research's February 2021 short report alleged fabricated revenue and overstated regulatory and manufacturing progress; the stock fell roughly 62%–63% in a single day, EHang publicly denied the allegations, and the consolidated SDNY securities case was dismissed with prejudice on January 24, 2023, with no fraud finding and no plaintiff appeal — a real vindication as far as it goes. What the report does not mention, and is worth adding honestly, is that a separate securities class action (covering ADS purchasers from March 29, 2022 through November 6, 2023) alleged EHang continued touting partnerships with United Therapeutics, DHL and Vodafone after those parties had reportedly abandoned the deals, and did not disclose that some pre-order customers were not genuine, creditworthy aviation businesses. A federal court in the Central District of California preliminarily approved a proposed class settlement in that case on October 17, 2025, with a final fairness hearing calendared for January 9, 2026. Settling is not an admission of wrongdoing, but reaching a court-approved settlement after roughly two years of litigation is a materially different outcome than the earlier case's outright dismissal, and the underlying theme — inflated order or pre-order quality — is the same one that resurfaced a third time in May 2026, when EHang's own internal review under ASC 606 found that some previously recognized revenue was not yet collectible, cutting 2025 revenue by about 18%, widening the loss, and costing the company its well-known-seasoned-issuer status.
The most credit-worthy part of this record is that EHang did file a formal, public restatement rather than staying silent — real disclosure discipline when forced to choose. But three separate order-quality or revenue-recognition episodes in five years is a pattern investors should weight more heavily than any single one of them in isolation, and it directly undercuts confidence that management would handle a genuine core-business disruption with the transparency and speed a five-to-ten-year growth thesis requires.